$0.01 (0.56%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Meeshanthini V. Dogan |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | CDIO |
| CUSIP | 14159C202 |
| CIK | 0001870144 |
| Web | https://cdio.ai |
| Phone | 855 226 9991 |
| Currency | USD |
| Employees | 15 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.06 |
| Payout Ratio | 0.00 |
| Current Ratio | 15.76 |
| Quick Ratio | 15.76 |
| Cash Ratio | 14.40 |
Sales & Book Value
| Annual Sales | $14825 |
| Price / Sales | 225.00 |
| Cash Flow | -2.14 |
| Price / Cash Flow | -0.61 |
| Price / Book | 0.57 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 1 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-3.71 |
| Trailing P/E Ratio | -0.53 |
| PEG Ratio | -0.04 |
| P/E Growth | -0.04 |
| Net Income | $-6.5M |
| Net Margin | -40152.50% |
| Pretax Margin | -40152.50% |
| Return on Equity | -78.82% |
| Return on Assets | -69.58% |
Financials Score
| AltmanZ Score | -2.54 |
| Piotroski Score | 1.00 |
| Working Capital | 7.25M |
| Total Assets | 9.56M |
| Ebit | -6.64M |
| Market Cap | 3.7M |
| Total Liabilities | 655.97K |
About Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Stock
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017. ...
2026-06-24 08:35:00
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics' tests, Epi+Gen CHD™ and PrecisionCHD™.
2026-05-27 08:35:00
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will exhibit at four upcoming national benefits conferences.
2026-05-20 08:00:00
AUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Frequently Asked Questions
What is the current Cardio Diagnostics Holdings, Inc. (CDIO) stock price?
Cardio Diagnostics Holdings, Inc.(NASDAQ:CDIO) stock price is $1.8 in the last trading session. During the trading session, CDIO stock reached the peak price of $7.91 while $0.97 was the lowest point it dropped to. The percentage change in CDIO stock occurred in the recent session was 0.56% while the dollar amount for the price change in CDIO stock was $0.01.
CDIO's industry and sector of operation?
The NASDAQ listed CDIO is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of CDIO?
Robert A. Philibert
| Co-Founder, Chief Medical Officer & Director
Timur Dogan
| Chief Technology Officer
Meeshanthini Dogan
| Co-Founder, Chief Executive Officer & Director
Elisa Michael Luqman
| Chief Financial Officer & Principal Accounting Officer
|
How many employees does CDIO have?
Number of CDIO employees currently stands at 15. CDIO operates from 400 N Aberdeen St, Chicago, IL 60642, US.
Link for CDIO official website?
Official Website of CDIO is: https://cdio.ai
How do I contact CDIO?
CDIO could be contacted at phone #855 226 9991 and can also be accessed through its website. CDIO operates from 400 N Aberdeen St, Chicago, IL 60642, US.
How many shares of CDIO are traded daily?
The average number of CDIO shares traded daily for last 3 months was 59.36K.
What is the market cap of CDIO currently?
The market value of CDIO currently stands at $3.73M with its latest stock price at $1.8